undamentalytics Newsletter

Evans Gary C: insider trades

Chief executive, Director at 2 companies we cover. 10 open-market purchases and 11 sales not made under a pre-set plan, reported from August 24, 2011 to August 28, 2026.

Would copying Evans Gary C’s purchases have beaten the S&P 500?

Too few purchases to judge. Only 1 purchase has 12 months of prices after the report; we judge insiders once they have 20. The figures below can swing a long way on a handful of trades. Buying each purchase the day after it was reported, an equal amount each, and holding it 12 months or until they reported a sale would have turned $10,000 on October 1, 2025 into $5,490 by November 2, 2026, −42.5% a year. The copy held shares only 92% of the time, so the fair comparison is the S&P 500 on those same days with Treasury bills otherwise: $11,595, +14.6% a year (the S&P 500 held throughout made $11,439, +13.2% a year). Beta against the index was 3.07. Twelve months after each report, the average purchase was −63.5% against the S&P 500 (median −63.5%), and 0% beat it. Measured from the trade date, the insider’s own timing, the average was −49.8%. After their sales, the shares moved −35.4% against the index over 12 months on average (a negative figure means selling was the right call); 67% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

$0$5.0k$10.0k$15.0k 20252026 $11.6k$11.4k$5.5k
Copying Evans Gary CS&P 500, same days investedS&P 500, held throughout $10,000 copying Evans Gary C’s open-market purchases from October 1, 2025, before costs and taxes, marked weekly. Each purchase gets the same starting stake, bought at the close of the first trading day after the report and sold 12 months later or the day after a reported sale of that stock; uninvested money earns the Treasury bill rate. “Same days invested” holds the S&P 500 only on the days the copy held shares, Treasury bills otherwise.
Return a year, copying
−42.5%
S&P 500, same days invested
+14.6% (held throughout +13.2%)
Time in shares
92%
Sharpe ratio (S&P 500)
0.14 (0.73)
Biggest drop (S&P 500)
−76% (−9%)
Market sensitivity (beta)
3.07
Purchases copied
1

Trade by trade

Evans Gary C: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 1 −35.8% −35.8% 0% 1 — — Not enough years
Purchases, 6 months after the report 1 +16.4% +16.4% 100% 1 — — Not enough years
Purchases, 12 months after the report 1 −63.5% −63.5% 0% 1 — — Not enough years
Purchases, 12 months after the trade 1 −49.8% −49.8% 0% 1 — — Not enough years
Sales, 3 months after the report 9 +1.6% +4.5% 44% 5 −0.16 0.88 No reliable evidence
Sales, 12 months after the report 9 −35.4% −51.7% 67% 5 −0.87 0.43 No reliable evidence
Sales, 12 months after the trade 9 −38.0% −54.6% 67% 5 −1.19 0.30 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Novavax Inc NVAX —011August 24, 2011June 3, 2021
United States Antimony Corp UAMY Chairman & CEO100December 9, 2022August 28, 2026

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
August 28, 2026August 28, 2026 UAMY Purchase $98,400 not yetnot yetnot yet
September 30, 2025September 26, 2025 UAMY Purchase $613,000 −35.8%−63.5%−49.8%
December 11, 2024December 10, 2024 UAMY Purchase $290,000 not yetnot yetnot yet
January 17, 2023January 13, 2023 UAMY Purchase $14,116 not yetnot yetnot yet
January 17, 2023January 11, 2023 UAMY Purchase $11,736 not yetnot yetnot yet
December 21, 2022December 10, 2022 UAMY Purchase $72,897 not yetnot yetnot yet
December 16, 2022December 15, 2022 UAMY Purchase $53,640 not yetnot yetnot yet
December 15, 2022December 13, 2022 UAMY Purchase $138,241 not yetnot yetnot yet
December 12, 2022December 7, 2022 UAMY Purchase $149,369 not yetnot yetnot yet
December 9, 2022December 6, 2022 UAMY Purchase $15,200 not yetnot yetnot yet
June 3, 2021June 1, 2021 NVAX Sale $91,562 +33.9%−74.0%−61.6%
March 17, 2021March 15, 2021 NVAX Sale $5,174,536 −25.3%−77.7%−73.5%
August 20, 2020August 18, 2020 NVAX Sale $1,579,620 −43.0%+48.7%+23.6%
June 7, 2016June 6, 2016 NVAX Sale $123,487 +4.5%−101.6%−101.7%
May 25, 2016May 23, 2016 NVAX Sale $270,323 +17.7%−100.2%−100.4%
August 26, 2015August 24, 2015 NVAX Sale $224,800 −36.9%−49.6%−49.1%
August 17, 2015August 13, 2015 NVAX Sale $81,387 −46.5%−51.7%−54.6%
December 18, 2014December 16, 2014 NVAX Sale $267,130 +53.4%+44.6%+49.4%
December 16, 2014December 12, 2014 NVAX Sale $173,100 +56.8%+43.1%+26.0%
April 26, 2013April 24, 2013 NVAX Sale $193,540 not yetnot yetnot yet
August 24, 2011June 22, 2011 NVAX Sale $849,923 not yetnot yetnot yet

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Evans Gary C traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.